Fengabine (SL-79229) is a drug which was investigated as an antidepressant but was never marketed. Its mechanism of action is unknown but its antidepressant effects are reversed by GABAA receptor antagonists like bicuculline and it has hence been labeled as GABAergic; however it does not actually bind to GABA receptors nor does it inhibit GABA-T.
This page contains content from the copyrighted Wikipedia article "Fengabine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
